Xencor to Present at Upcoming Investor Conferences

Rhea-AI Summary

Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company focused on engineered monoclonal antibodies and cytokines for cancer and autoimmune diseases, will participate in two virtual investor conferences. The first is the Guggenheim Healthcare Talks | 2022 Oncology Conference on February 9, 2022, at 2:00 p.m. EST. The second is the 11th Annual SVB Leerink Global Healthcare Conference on February 16, 2022, at 3:40 p.m. EST. Live webcasts will be accessible on Xencor's website, with replays available for 30 days.

MONROVIA, Calif.--(BUSINESS WIRE)-- Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases, today announced that company management will participate at two upcoming virtual investor conferences:

• Guggenheim Healthcare Talks | 2022 Oncology Conference
  Presentation Date: Wednesday, February 9, 2022
  Presentation Time: 2:00 p.m. EST / 11:00 a.m. PST

• 11th Annual SVB Leerink Global Healthcare Conference
  Presentation Date: Wednesday, February 16, 2022
  Presentation Time: 3:40 p.m. EST / 12:40 p.m. PST

Live webcasts of the presentations will be available under "Events & Presentations" in the Investors section of the Company's website located at www.xencor.com. Replays will be posted on the Xencor website approximately one hour after the live event and will be available for at least 30 days.

About Xencor, Inc.

Xencor is a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases. Currently, 22 candidates engineered with Xencor's XmAb^® technology are in clinical development internally and with partners. Xencor's XmAb antibody engineering technology enables small changes to the structure of proteins resulting in new mechanisms of therapeutic action. For more information, please visit www.xencor.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220202005908/en/

Charles Liles

cliles@xencor.com

Media Contact

Jason I. Spark

Canale Communications

619-849-6005

jason@canalecomm.com

Source: Xencor, Inc.

FAQ

What conferences will Xencor, Inc. participate in February 2022?

Xencor, Inc. will participate in the Guggenheim Healthcare Talks | 2022 Oncology Conference on February 9, 2022, and the 11th Annual SVB Leerink Global Healthcare Conference on February 16, 2022.

What is the date and time for the Guggenheim Healthcare Talks event?

The Guggenheim Healthcare Talks event is scheduled for February 9, 2022, at 2:00 p.m. EST.

When will Xencor's presentation at the SVB Leerink Global Healthcare Conference take place?

Xencor's presentation at the SVB Leerink Global Healthcare Conference will occur on February 16, 2022, at 3:40 p.m. EST.

Where can I watch Xencor's conference presentations?

Xencor's conference presentations will be available via live webcasts on the Company's website under the 'Events & Presentations' section.

How long will the replays of Xencor's presentations be available?

Replays of Xencor's presentations will be posted approximately one hour after the live event and will be available for at least 30 days.